Risk factors for hepatitis C on the Texas-Mexico border

American Journal of Gastroenterology

Volumn 100, Issue 10, 2005, Pages 2180-2185

  Hand, W Lee ^a   Vasquez, Yvonne ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK FACTOR; SEROLOGY; TATTOO; UNITED STATES; ADDICTION; ARTICLE; CASE CONTROL STUDY; HISPANIC; MIDDLE AGED; PROSPECTIVE STUDY; SEXUAL BEHAVIOR; STATISTICS; TATTOOING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C; HISPANIC AMERICANS; HUMANS; MALE; MEXICO; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; TATTOOING; TEXAS;

EID: 27744588050     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00238.x     Document Type: Review

References (32)

1. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999 107 ( 6B 2S 9.
2. Younossi ZM. Epidemiology and clinical features of hepatitis viruses - hepatitis C. Cleve Clin J Med 2000 67 ( S1 9 11.
3. Lauer GM Walker BD. Hepatitis C virus infection. N Engl J Med 2001 345 : 41 52.
4. Centers for Disease Control and Prevention. National hepatitis C prevention strategy. A comprehensive strategy for the prevention and control of hepatitis C virus infection and its consequences. 2001 1 19.
5. Alter MJ Kruszon-Moran D Nainan OU, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999 341 : 556 62.
6. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998 47 ( No. RR-19 1 39.
7. National Institutes of Health. Management of hepatitis C. NIH consensus statement 1997 15 ( 3 1 41.
8. National Institutes of Health. Management of hepatitis C: 2002. Consensus Development Conference Statement 2002 1 44.
9. Vandelli C Renzo F Romano L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a 10-year prospective follow-up study. Am J Gastroenterol 2004 99 : 855 9.
10. Sulkowski MS Ray SC Thomas DL. Needlestick transmission of hepatitis C. JAMA 2002 287 : 2406 13.
11. Balasekaran R Bulterys M Jamal M, et al. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol 1999 94 : 1341 6.
12. Haley RW Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection: Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine 2001 80 : 134 51.
13. Samuel MC Doherty PM Bulterys M, et al. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect 2001 127 : 475 84.
14. Haley RW Fischer RP. The tattooing paradox. Are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection? Arch Intern Med 2003 163 : 1095 8.
15. Dieterich DT. Hepatitis C virus and human immunodeficiency virus: Clinical issues in coinfection. Am J Med 1999 107 ( 6B 79S 84S.
16. Talal A. Opportunistic infections in HIV-infected individuals: Hepatitis C virus. Lancet 2002 360 : 584 6.
17. Dieterich DT. Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients. J Infect Dis 2002 185 ( Suppl 2 S128 37.
18. Sulkowski MS Moore RD Mehta SH, et al. Hepatitis C and progression of HIV disease. JAMA 2002 288 : 199 206.
19. Rossi SJ Volberding PA Wright TL. Does hepatitis C virus infection increase the risk of HIV disease progression? JAMA 2002 288 : 241 3.
20. Sulkowski MS Thomas DL. Hepatitis C in the HIV-infected person. Ann Int Med 2003 138 : 197 207.
21. Tedaldi EM Baker RK Moorman AC, et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2003 36 : 363 7.
22. Quirishi N Kreuzberg C Lüchters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C coinfection. Lancet 2003 362 : 1708 13.
23. Alatrakchi N Koziel MJ. A tale of two viruses: Hepatitis C in the age of HAART. Lancet 2003 362 : 1687 8.
24. Anderson KB Guest JL Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: Data from the HIV Atlanta VA cohort study. Clin Infect Dis 2004 39 : 1507 13.
25. Yoo TW Donfield S Lail A, et al. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis 2005 191 : 4 10.
26. Nunez M Soriano V. Hepatitis C virus (HCV) genotype and disease progression in HIV/HCV-coinfected patients. J Infect Dis 2005 191 : 1 3.
27. Dufour MC. What is moderate drinking? Defining "drinks" and drinking levels. Alcohol Res Health 1999 23 : 5 14.
28. Kaldor JM Archer GT Buring ML, et al. Risk factors for hepatitis C virus infection in blood donors: A case-control study. Med J Aust 1992 157 : 227 30.
29. Mele A Corona R Tosti ME, et al. Beauty treatments and risk of parenterally transmitted hepatitis: Results from the hepatitis surveillance system in Italy. Scand J Infect Dis 1995 27 : 441 4.
30. Sun D-X Zhang F-G Geng Y-Q, et al. Hepatitis C transmission by cosmetic tattooing in women. Lancet 1996 347 : 541.
31. Schiff ER. The alcoholic patient with hepatitis C virus infection. Am J Med 1999 107 ( 6B 95S 9S.
32. Lieber CS. Hepatitis C and alcohol. J Clin Gastroenterol 2003 36 : 100 2.